SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CACCIARI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.204
AS - Asia 2.049
EU - Europa 2.036
SA - Sud America 106
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.168
CN - Cina 977
UA - Ucraina 662
SG - Singapore 484
TR - Turchia 444
DE - Germania 393
GB - Regno Unito 275
SE - Svezia 215
IT - Italia 167
FI - Finlandia 156
BR - Brasile 94
VN - Vietnam 62
FR - Francia 39
PL - Polonia 38
CA - Canada 33
HK - Hong Kong 30
RU - Federazione Russa 25
BE - Belgio 21
ID - Indonesia 17
IN - India 12
NL - Olanda 10
LT - Lituania 9
AR - Argentina 5
CZ - Repubblica Ceca 4
IE - Irlanda 4
AT - Austria 3
BG - Bulgaria 3
ES - Italia 3
IQ - Iraq 3
IR - Iran 3
KR - Corea 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CH - Svizzera 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
UZ - Uzbekistan 2
VE - Venezuela 2
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SD - Sudan 1
Totale 12.403
Salva come PNG Salva come JPEG
Città #
Woodbridge 977
Fairfield 914
Houston 770
Jacksonville 711
Ashburn 660
Chandler 593
Ann Arbor 488
Santa Clara 398
Wilmington 356
Seattle 350
Cambridge 264
Singapore 245
Nanjing 243
Izmir 220
Princeton 158
Boardman 111
Beijing 109
San Diego 89
Shenyang 77
Nanchang 67
Dong Ket 61
Ferrara 41
Jiaxing 41
Shanghai 41
Milan 40
Los Angeles 37
San Mateo 37
Hebei 34
Tianjin 34
Kunming 32
Warsaw 31
Changsha 30
Dearborn 30
Hong Kong 28
Jinan 28
Zhengzhou 27
Falls Church 26
Helsinki 26
Norwalk 22
Brussels 21
Falkenstein 20
Philadelphia 19
Ningbo 18
Addison 17
London 16
Guangzhou 15
Jakarta 15
Munich 15
New York 15
Bremen 14
Mountain View 14
Taizhou 14
Toronto 13
Verona 13
Montréal 12
Redwood City 12
São Paulo 12
Indiana 11
Washington 11
Augusta 9
Frankfurt am Main 9
Mcallen 9
Orange 9
Auburn Hills 8
Des Moines 8
Redmond 8
Tappahannock 7
Bologna 6
Hangzhou 6
Leawood 6
Amsterdam 5
Düsseldorf 5
Haikou 5
Kilburn 5
Ottawa 5
Weihai 5
Chiswick 4
Dublin 4
Hefei 4
Lanzhou 4
Rome 4
San Francisco 4
Yellow Springs 4
Baghdad 3
Berlin 3
Brno 3
Changchun 3
Chicago 3
Ferrara di Monte Baldo 3
Fortaleza 3
Fuzhou 3
Istanbul 3
Las Vegas 3
Monmouth Junction 3
Nantong 3
New Bedfont 3
Senador Canedo 3
Trieste 3
Vienna 3
Villafranca Padovana 3
Totale 8.937
Salva come PNG Salva come JPEG
Nome #
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 370
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 312
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 178
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 161
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 147
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 136
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 135
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists 134
Synthesis and antitumor activity of novel distamycin derivatives 129
The influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl moiety on the adenosine receptors affinity profile of pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c] pyrimidine derivatives 129
New potent and selective human adenosine A3 receptor antagonists. 123
Synthesis and calcium antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(nitrogenous heteroaryl)-3,5-pyridine dicarboxylates. 122
DNA minor groove alkylating agents structurally related to distamycin A 121
A new synthetic approach to indazole synthesis 118
null 118
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach 118
Oligonucleotides and oligonucleotide conjugates: A new approach for cancer treatment 117
8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligands 116
Synthesis and antitumor activity of a new class of pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone analogs of pyrrolo[1,4]benzodiazepines (PBDs) 115
New 9-methyl-8-(4-hydroxyphenyl)adenine derivatives as A1 adenosine receptor antagonists 114
A2A-adenosine receptor reserve for coronary vasodilation 114
Nitrile oxide [3 + 2] cycloaddition: application to the synthesis of 6-substituted 3(2H)-pyridazinones and 6-substituted 4,5-dihydro-4-hydroxy-3(2H)-pyridazinones 113
DNA minor-groove binders: results and design of new antitumor agents 110
Design, synthesis and biological activity of a pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid 110
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity 110
Structure-activity relationship of novel tallimustine derivatives: Synthesis and antitumor activity 109
Carbon nanotube substrates boost neuronal electrical signaling 109
Selective binding to human genomic sequences of two synthetic analogues structurally related to U-71184 and adozelesin 108
An efficient procedure for the synthesis of 5H-6-substituted-pyrazolo[1,5-d]-1,2,4-triazine-4,7-diones 107
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors 107
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 106
Synthesis and Antitumor Activity of a New Class of Pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone Analogs of Pyrrolo[1,4][2,1-c]benzodiazepines 106
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 106
Facile and versatile route to the synthesis of fused 2-pyridones: Useful intermediates for polycyclic sytems 105
null 104
Ethyl-(R,S)-5-acetyl-4,5-dihydro-3-isoxazole acetate 104
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 104
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile 103
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo- pyrimidine antagonists binding site of the human adenosine A2A receptor 102
Ethyl (R,S)-5-acetyl-4,5-dihydro-3-isoxazoleacetate 102
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 102
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 101
New potent and selective human adenosine A3 receptor antagonists 101
Synthesis and properties of substituted CBI analogs of CC-1065 and the duocarmycins incorporating the 7-methoxy-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (MCBI) alkylation subunit: Magnitude of electronic effects on the functional reactivity 100
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA3 Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 100
Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c] [1,4]benzodiazepines 100
Chemical synthesis of [13C]daidzein. 99
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors 99
CC-1065 and the duocarmycins: recent developments 98
Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A(2A) Adenosine Receptor Antagonists with Improved Water Solubility 98
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 97
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 96
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes 96
Exploring Potency and Selectivity Receptor Antagonist Profiles Using a Multilabel Classification Approach: The Human Adenosine Receptors as a Key Study 95
Synthesis of pyridazine derivatives through the unexpected intermediate 5-amino-4-cyano-2,3-dihydro-furan-2,3-disulfonic acid disodium salt 95
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 95
Recent developments in the field of adenosine receptor ligands 94
Cosmetic preservation and structure-activity relationships of 4-diazo-pyrazole-5-carboxamides 94
Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonists 94
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 94
Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling 92
null 90
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 90
Carbon Nanotubes Carrying Cell-Adhesion Peptides do not Interfere with Neuronal Functionality 89
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 89
A(3) adenosine receptor ligands: History and perspectives 88
null 87
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors 87
7-sobstituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonist: importance of modifications at the side chain on the activity and solubility. 86
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process 86
Substituted 6-amino-thiouracils as new P2Y(12) receptor antagonists 85
A(1) and A(3) adenosine receptor agonists: an overview 85
Novel N-6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A(3) adenosine receptors 83
Pyrazolo [4,3-E]1,2,4-triazolo[1,5-c]pyrimidine derivates a new class of potent and selective human A3 adenosine receptor antagonists. 83
Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridinedicarboxylates. 2 82
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists 80
Unusual Ring-Opening Reaction of 6,7-Dihydrothieno[3,2-d]pyrimidine- 2,4-dione Derivatives Leading to 5-(Alkylthio)-6-vinyluracils 79
Synthesis and Biological Activity of a New Series of N6-Arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-Carboxamido Derivatives of Adenosine-5'-N-ethyluronamide as A1 and A3 Adenosine Receptor Agonists 78
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists 77
null 77
Synthesis, biological and modeling studies of new water soluble hA3 adenosine receptor antagonists. 76
Rationale design of new human adenosione A3 receptor antagonists through a CoMFA model. 75
Pyridazine nucleus: a pharmacophoric moiety for bio-active compounds 75
Synthesis, binding and thermodynamic studies of new highly selective A2A adenosine receptor antagonists 75
Synthesis, antibacterial activity and structure-activity relationships of N-substituted 4-diazopyrazole-5-carboxamides. 2 74
Heterocyclic analogs of DNA minor groove alkylating agents 74
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A2A adenosine antagonists 74
A2Aadenosine receptor antagonists as therapeutic candidates: Are they still an interesting challenge? 74
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 73
Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity 72
Synthesis and molecular investigation of new pyrazolo[4,3-e]1,2,4,-triazolo[1,5-c]pyrimidine derivates as human A3 adenosine receptor antagonists. 72
Current developments of A(2a) adenosine receptor antagonists 71
Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A(2A) antagonists 70
Triazolo-triazine as new adenosine receptor antagonists. 68
Conjugation of Dopamine and an A2A Adenosine Receptor Antagonist: a possible approach for the treatment of Parkinson’s Disease. 68
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 67
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist 66
Binding affinity of adenosine receptor agonists and antagonists at human A3 adenosine receptors 66
Synthesis and pharmacological characterization of [3H]-MRE3008F20: the first radioligand antagonist for the human A3 adenosine receptors. 65
A novel class of pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A3 adenosine receptor antagonists 65
Totale 10.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 331
Totale 61.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020542 0 0 0 0 0 0 0 0 165 265 75 37
2020/20211.641 144 145 112 183 50 167 32 199 36 188 232 153
2021/20221.361 39 138 78 135 85 51 42 83 38 98 153 421
2022/20231.317 158 63 26 171 220 223 31 118 173 8 73 53
2023/2024810 70 92 34 21 71 60 20 260 12 12 10 148
2024/20251.318 75 134 196 79 329 171 55 201 78 0 0 0
Totale 12.524